Azole resistance: patterns of amino acid substitutions in Candida sterol 14α-demethylase
- PMID: 40246735
- DOI: 10.1007/s10482-025-02080-1
Azole resistance: patterns of amino acid substitutions in Candida sterol 14α-demethylase
Abstract
The emergence of azole-resistant Candida infections is a major concern. A key mechanism is the gain of resistance through amino acid substitutions in the sterol 14α-demethylase, the main target of azole drugs. While numerous resistant substitutions are known, the pattern of such substitutions remains unclear. We hypothesized that resistant substitutions occur disproportionately at azole-binding sites. We compiled 2222 instances of azole-resistant substitutions from the literature and performed extensive computational sequence analyses. Altogether, there were 169 known substitutions at 133 sites in sterol 14α-demethylases of seven Candida species, whereas C. albicans alone had 120 substitutions at 97 sites. Just 10 sites and 18 substitutions (such as Y132F/H, K143R, D116E, and G464S) accounted for 75% of the total instances. Only about 48% of the sites were present within previously recognized hotspot regions, while just 33% of the azole-interacting residues had known resistant substitutions, most of them with only a few instances. The literature data on azole-resistant substitutions in Candida appear to be highly biased, as a few substitutions, such as Y132F/H and K143R, were preferentially sought and reported with over 1,000 instances. Additionally, there were numerous reports of "resistant" substitutions in azole-susceptible Candida isolates. Our study provides new perspectives into azole resistance.
Keywords: Amino acid substitution; Antifungal resistance; Azole binding; Candida infection; Computational sequence analysis.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: The work is in compliance with ethical standards. No ethical clearance was necessary.
References
-
- Arastehfar A, Daneshnia F, Hilmioğlu-Polat S et al (2020a) First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and/or Y132F+K143R in Turkey. Antimicrobial Agents Chemother 64:aac.01001-20 - DOI
-
- Arastehfar A, Daneshnia F, Najafzadeh MJ et al (2020b) Evaluation of molecular epidemiology, clinical characteristics, antifungal susceptibility profiles, and molecular mechanisms of antifungal resistance of Iranian Candida parapsilosis species complex blood isolates. Front Cell Infect Microbiol 10:206 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
